These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 17909065

  • 1. Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone.
    Zheng Y, Zhou H, Modzelewski JR, Kalak R, Blair JM, Seibel MJ, Dunstan CR.
    Cancer Res; 2007 Oct 01; 67(19):9542-8. PubMed ID: 17909065
    [Abstract] [Full Text] [Related]

  • 2. Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone.
    Gordon AH, O'Keefe RJ, Schwarz EM, Rosier RN, Puzas JE.
    Cancer Res; 2005 Apr 15; 65(8):3209-17. PubMed ID: 15833852
    [Abstract] [Full Text] [Related]

  • 3. Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically.
    Fisher JL, Thomas-Mudge RJ, Elliott J, Hards DK, Sims NA, Slavin J, Martin TJ, Gillespie MT.
    Cancer Res; 2006 Apr 01; 66(7):3620-8. PubMed ID: 16585187
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis.
    Ooi LL, Zhou H, Kalak R, Zheng Y, Conigrave AD, Seibel MJ, Dunstan CR.
    Cancer Res; 2010 Mar 01; 70(5):1835-44. PubMed ID: 20160035
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Low calcium:phosphorus ratio in habitual diets affects serum parathyroid hormone concentration and calcium metabolism in healthy women with adequate calcium intake.
    Kemi VE, Kärkkäinen MU, Rita HJ, Laaksonen MM, Outila TA, Lamberg-Allardt CJ.
    Br J Nutr; 2010 Feb 01; 103(4):561-8. PubMed ID: 19781123
    [Abstract] [Full Text] [Related]

  • 7. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.
    Kelly T, Suva LJ, Huang Y, Macleod V, Miao HQ, Walker RC, Sanderson RD.
    Cancer Res; 2005 Jul 01; 65(13):5778-84. PubMed ID: 15994953
    [Abstract] [Full Text] [Related]

  • 8. Magnesium deficiency: effect on bone and mineral metabolism in the mouse.
    Rude RK, Gruber HE, Wei LY, Frausto A, Mills BG.
    Calcif Tissue Int; 2003 Jan 01; 72(1):32-41. PubMed ID: 12370796
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model.
    Yang M, Burton DW, Geller J, Hillegonds DJ, Hastings RH, Deftos LJ, Hoffman RM.
    Clin Cancer Res; 2006 Apr 15; 12(8):2602-6. PubMed ID: 16638872
    [Abstract] [Full Text] [Related]

  • 12. Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivo.
    van der Pluijm G, Que I, Sijmons B, Buijs JT, Löwik CW, Wetterwald A, Thalmann GN, Papapoulos SE, Cecchini MG.
    Cancer Res; 2005 Sep 01; 65(17):7682-90. PubMed ID: 16140935
    [Abstract] [Full Text] [Related]

  • 13. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
    Ottewell PD, Deux B, Mönkkönen H, Cross S, Coleman RE, Clezardin P, Holen I.
    Clin Cancer Res; 2008 Jul 15; 14(14):4658-66. PubMed ID: 18628481
    [Abstract] [Full Text] [Related]

  • 14. A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D(3) in breast cancer patients with bone metastases.
    Amir E, Simmons CE, Freedman OC, Dranitsaris G, Cole DE, Vieth R, Ooi WS, Clemons M.
    Cancer; 2010 Jan 15; 116(2):284-91. PubMed ID: 19918922
    [Abstract] [Full Text] [Related]

  • 15. Bone resorption activity of osteolytic metastatic lung and breast cancers.
    Shih LY, Shih HN, Chen TH.
    J Orthop Res; 2004 Nov 15; 22(6):1161-7. PubMed ID: 15475192
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis.
    Zheng Y, Zhou H, Brennan K, Blair JM, Modzelewski JR, Seibel MJ, Dunstan CR.
    Bone; 2007 Feb 15; 40(2):471-8. PubMed ID: 17092788
    [Abstract] [Full Text] [Related]

  • 17. Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis.
    Ooi LL, Zheng Y, Zhou H, Trivedi T, Conigrave AD, Seibel MJ, Dunstan CR.
    Bone; 2010 Oct 15; 47(4):795-803. PubMed ID: 20638491
    [Abstract] [Full Text] [Related]

  • 18. Cilengitide inhibits metastatic bone colonization in a nude rat model.
    Bretschi M, Merz M, Komljenovic D, Berger MR, Semmler W, Bäuerle T.
    Oncol Rep; 2011 Oct 15; 26(4):843-51. PubMed ID: 21725616
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increased Dickkopf-1 expression in breast cancer bone metastases.
    Voorzanger-Rousselot N, Goehrig D, Journe F, Doriath V, Body JJ, Clézardin P, Garnero P.
    Br J Cancer; 2007 Oct 08; 97(7):964-70. PubMed ID: 17876334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.